FDA Inspection 872306 — ImpactLife

ImpactLife — FEI 3003319042

The FDA completed an inspection of ImpactLife on Mar 31, 2014 in Galesburg, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Mar 31, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Galesburg, IL (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.